CARG-2020

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCARG-2020
Drug Alias NameCARG-2020
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapyBiologics > Protein drugs +[4] 
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicityRNA interference +[6] 
TargetsInterleukin-12Interleukin-17Programmed death-ligand 1
Therapy Area/IndicationsOvarian NeoplasmsColorectal NeoplasmsPeritoneal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarogen Corp
China Registration ClassN/A

Develop Information

Active CompaniesCarogen Corp
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsColorectal NeoplasmsPeritoneal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A